Brief: Oasmia Q2 Operating Loss Widens To SEK 53.7 Mln

Vivesto AB

09/12/2020 07:05

Dec 9 (Reuters) - Oasmia Pharmaceutical AB  OASM.ST :
    * Q2 CONSOLIDATED NET SALES AMOUNTED TO TSEK 154 (252)
    * Q2 OPERATING LOSS WAS TSEK -53,693 (-47,436)

Source text for Eikon:  ID:nMFN4mljmJ 
Further company coverage:  OASM.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))